The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $96.97

Today's change0.00 0.00%
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

CME Group Inc

Nasdaq: CME
Last

(U.S.) $96.97

Today's change0.00 0.00%
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.

CME Group Inc closed at (U.S.)$96.97.

Over the last five days, shares have gained 1.49% and are currently 3.87% off of the 52-week high. Shares have outperformed the S&P 500 by 21.74% during the last year.

Key company metrics

  • Open(U.S.) $96.37
  • Previous close(U.S.) $96.97
  • High(U.S.) $97.11
  • Low(U.S.) $96.09
  • Bid / Ask-- / --
  • YTD % change+9.39%
  • Volume1,193,987
  • Average volume (10-day)1,252,277
  • Average volume (1-month)1,349,339
  • Average volume (3-month)1,395,978
  • 52-week range(U.S.) $72.25 to (U.S.) $100.87
  • Beta1.08
  • Trailing P/E27.42×
  • P/E 1 year forward25.08×
  • Forward PEG2.17×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.06%
  • Trailing EPS(U.S.) $3.54
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+36.49%

Based on its net profit margin of 36.49%, CME Group Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:FinancialsIndustry:Investment Services
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue820843841762
Total other revenue--------
Total revenue820843841762
Gross profit--------
Total cost of revenue--------
Total operating expense325335370332
Selling / general / administrative244247258236
Research & development--------
Depreciation / amortization58575658
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total22325538
Operating income495507472430
Interest income (expense), net non-operating-29-32-29-29
Gain (loss) on sale of assets--------
Other--------
Income before tax448524474429
Income after tax265330307290
Income tax, total183193167139
Net income265330307290
Total adjustments to net income--------
Net income before extra. items265330307290
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items265330307290
Inc. avail. to common incl. extra. items265330307290
Diluted net income265330307290
Dilution adjustment--0----
Diluted weighted average shares338337337336
Diluted EPS excluding extraordinary itemsvalue per share0.780.980.910.86
Dividends per sharevalue per share0.500.502.470.47
Diluted normalized EPSvalue per share0.780.980.910.86